CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
Europe - OSL:CONTX - SE0014731154 - Common Stock
3.83 NOK
-0.02 (-0.52%)
We assign a fundamental rating of 5 out of 10 to CONTX. CONTX was compared to 10 industry peers in the Health Care Technology industry. While CONTX has a great profitability rating, there are some minor concerns on its financial health. CONTX does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year CONTX was profitable.
In the past year CONTX had a positive cash flow from operations.
CONTX had positive earnings in 4 of the past 5 years.
In the past 5 years CONTX always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 7.66%, CONTX perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
CONTX has a Return On Equity of 10.25%. This is comparable to the rest of the industry: CONTX outperforms 50.00% of its industry peers.
With a decent Return On Invested Capital value of 8.96%, CONTX is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CONTX is significantly above the industry average of 9.03%.
The last Return On Invested Capital (8.96%) for CONTX is well below the 3 year average (36.72%), which needs to be investigated, but indicates that CONTX had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROIC | 8.96% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
The Profit Margin of CONTX (7.86%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CONTX has grown nicely.
CONTX's Operating Margin of 9.33% is in line compared to the rest of the industry. CONTX outperforms 60.00% of its industry peers.
In the last couple of years the Operating Margin of CONTX has grown nicely.
With an excellent Gross Margin value of 97.46%, CONTX belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
CONTX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CONTX is creating value.
Compared to 1 year ago, CONTX has about the same amount of shares outstanding.
The number of shares outstanding for CONTX remains at a similar level compared to 5 years ago.
CONTX has a worse debt/assets ratio than last year.
2.2 Solvency
CONTX has a debt to FCF ratio of 1.49. This is a very positive value and a sign of high solvency as it would only need 1.49 years to pay back of all of its debts.
CONTX's Debt to FCF ratio of 1.49 is in line compared to the rest of the industry. CONTX outperforms 60.00% of its industry peers.
CONTX has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.07, CONTX is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | N/A |
ROIC/WACC0.87
WACC10.26%
2.3 Liquidity
CONTX has a Current Ratio of 4.12. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 4.12, CONTX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CONTX has a Quick Ratio of 4.07. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
CONTX's Quick ratio of 4.07 is amongst the best of the industry. CONTX outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 |
3. Growth
3.1 Past
CONTX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -64.19%.
The Earnings Per Share has been growing by 27.26% on average over the past years. This is a very strong growth
CONTX shows a decrease in Revenue. In the last year, the revenue decreased by -9.99%.
The Revenue has been growing slightly by 6.51% on average over the past years.
EPS 1Y (TTM)-64.19%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
Revenue 1Y (TTM)-9.99%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-12.48%
3.2 Future
The Earnings Per Share is expected to decrease by -3.57% on average over the next years.
CONTX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.76% yearly.
EPS Next Y-106.9%
EPS Next 2Y-25.72%
EPS Next 3Y-3.57%
EPS Next 5YN/A
Revenue Next Year-6.41%
Revenue Next 2Y-2.61%
Revenue Next 3Y-1.08%
Revenue Next 5Y1.76%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 29.46, CONTX can be considered very expensive at the moment.
CONTX's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of CONTX to the average of the S&P500 Index (25.67), we can say CONTX is valued inline with the index average.
The Price/Forward Earnings ratio is 21.78, which indicates a rather expensive current valuation of CONTX.
The rest of the industry has a similar Price/Forward Earnings ratio as CONTX.
CONTX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 31.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.46 | ||
| Fwd PE | 21.78 |
4.2 Price Multiples
CONTX's Enterprise Value to EBITDA ratio is in line with the industry average.
CONTX's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 47.23 | ||
| EV/EBITDA | 11.38 |
4.3 Compensation for Growth
CONTX has a very decent profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as CONTX's earnings are expected to decrease with -3.57% in the coming years.
PEG (NY)N/A
PEG (5Y)1.08
EPS Next 2Y-25.72%
EPS Next 3Y-3.57%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
CONTX's Dividend Yield is rather good when compared to the industry average which is at 3.43. CONTX pays more dividend than 90.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, CONTX pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-25.72%
EPS Next 3Y-3.57%
OSL:CONTX (11/7/2025, 3:03:01 PM)
3.83
-0.02 (-0.52%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap296.33M
Revenue(TTM)119.16M
Net Income(TTM)9.36M
Analysts40
Price Target5.1 (33.16%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-124.27%
Min EPS beat(2)-148.54%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.12%
Min Revenue beat(2)-29.34%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-104.88%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.46 | ||
| Fwd PE | 21.78 | ||
| P/S | 2.33 | ||
| P/FCF | 47.23 | ||
| P/OCF | 20.37 | ||
| P/B | 3.04 | ||
| P/tB | 3.14 | ||
| EV/EBITDA | 11.38 |
EPS(TTM)0.13
EY3.39%
EPS(NY)0.18
Fwd EY4.59%
FCF(TTM)0.08
FCFY2.12%
OCF(TTM)0.19
OCFY4.91%
SpS1.64
BVpS1.26
TBVpS1.22
PEG (NY)N/A
PEG (5Y)1.08
Graham Number1.92
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROCE | 11.34% | ||
| ROIC | 8.96% | ||
| ROICexc | 31.76% | ||
| ROICexgc | 35.3% | ||
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% | ||
| FCFM | 4.93% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 96.94% | ||
| Cap/Sales | 6.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.3% | ||
| Profit Quality | 62.81% | ||
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 | ||
| Altman-Z | N/A |
F-Score5
WACC10.26%
ROIC/WACC0.87
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-64.19%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-100%
EPS Next Y-106.9%
EPS Next 2Y-25.72%
EPS Next 3Y-3.57%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.99%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-12.48%
Revenue Next Year-6.41%
Revenue Next 2Y-2.61%
Revenue Next 3Y-1.08%
Revenue Next 5Y1.76%
EBIT growth 1Y-64.61%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-32.14%
EBIT Next 3Y9.74%
EBIT Next 5YN/A
FCF growth 1Y-82.88%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-68.39%
OCF growth 3Y51.49%
OCF growth 5Y5.6%
CONTEXTVISION AB / CONTX.OL FAQ
What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.
What is the valuation status of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a valuation rating of 3 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Overvalued.
How profitable is CONTEXTVISION AB (CONTX.OL) stock?
CONTEXTVISION AB (CONTX.OL) has a profitability rating of 7 / 10.
How financially healthy is CONTEXTVISION AB?
The financial health rating of CONTEXTVISION AB (CONTX.OL) is 6 / 10.
Can you provide the expected EPS growth for CONTX stock?
The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -106.9% in the next year.